KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to -$484.0 million.

  • Amgen's Change in Account Payables fell 10862.07% to -$484.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $428.0 million, marking a year-over-year increase of 3717.95%. This contributed to the annual value of $428.0 million for FY2025, which is 3717.95% up from last year.
  • Latest data reveals that Amgen reported Change in Account Payables of -$484.0 million as of Q4 2025, which was down 10862.07% from -$174.0 million recorded in Q3 2025.
  • In the past 5 years, Amgen's Change in Account Payables ranged from a high of $643.0 million in Q2 2024 and a low of -$484.0 million during Q4 2025
  • In the last 5 years, Amgen's Change in Account Payables had a median value of -$74.0 million in 2021 and averaged $21.2 million.
  • Per our database at Business Quant, Amgen's Change in Account Payables tumbled by 84285.71% in 2021 and then skyrocketed by 206086.96% in 2025.
  • Quarter analysis of 5 years shows Amgen's Change in Account Payables stood at $191.0 million in 2021, then soared by 54.97% to $296.0 million in 2022, then tumbled by 163.18% to -$187.0 million in 2023, then dropped by 24.06% to -$232.0 million in 2024, then crashed by 108.62% to -$484.0 million in 2025.
  • Its Change in Account Payables stands at -$484.0 million for Q4 2025, versus -$174.0 million for Q3 2025 and $589.0 million for Q2 2025.